Redefining Roles: A Paradigm Shift in Tryptophan–Kynurenine Metabolism for Innovative Clinical Applications
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The tryptophan–kynurenine (KYN) pathway has long been recognized for its essential role in generating metabolites that influence various physiological processes. Traditionally, these metabolites have been categorized into distinct, often opposing groups, such as pro-oxidant versus antioxidant, excitotoxic/neurotoxic versus neuroprotective. This dichotomous framework has shaped much of the research on conditions like neurodegenerative and neuropsychiatric disorders, as well as cancer, where metabolic imbalances are a key feature. The effects are significantly influenced by various factors, including the concentration of metabolites and the particular cellular milieu in which they are generated. A molecule that acts as neuroprotective at low concentrations may exhibit neurotoxic effects at elevated levels. The oxidative equilibrium of the surrounding environment can alter the function of KYN from an antioxidant to a pro-oxidant. This narrative review offers a comprehensive examination and analysis of the contemporary understanding of KYN metabolites, emphasizing their multifaceted biological functions and their relevance in numerous physiological and pathological processes. This underscores the pressing necessity for a paradigm shift in the comprehension of KYN metabolism. Understanding the context-dependent roles of KYN metabolites is vital for novel therapies in conditions like Alzheimer’s disease, multiple sclerosis, and cancer. Comprehensive pathway modulation, including balancing inflammatory signals and enzyme regulation, offers promising avenues for targeted, effective treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health
Cervenka, I., Agudelo, L. Z., & Ruas, J. L. (2017) · Science · doi:10.1126/science.aaf9794 · Cited by 1,382 · cited 2×
“Studies have revealed the molecular mechanisms linking muscle activity to brain health, emphasizing the role of muscle-derived enzymes in shaping KYN metabolism and reducing the harmful effects of stress and neurotoxicity [16,342–344] (Figure 3).”
The microbiota-gut-brain axis: from motility to mood
Margolis, K. G., Cryan, J. F., & Mayer, E. A. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.10.066 · Cited by 999 · cited 1×
“…the gut and brain opens new avenues for understanding psychiatric and neuro-degenerative diseases, highlighting how gut health impacts mental and neurological well-being [309,310] (Figure 3). metabolism, diverting it through the KYN pathway and producing metabolites that affect brain processes.”
Long, G. V., Dummer, R., Hamid, O., Gajewski, T. F., Caglevic, C., Dalle, S., Arance, A., Carlino, M. S., Grob, J.-J., Kim, T. M., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30274-8 · Cited by 960 · cited 1×
“IDO1 inhibitors such as epacadostat have been tested in advanced stages as standalone treatments or in combination with immune checkpoint inhibitors, but some studies, including Phase III trials, have struggled to meet primary endpoints [515–517].”
Physical activity and muscle-brain crosstalk
Pedersen, B. K. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0174-x · Cited by 772 · cited 1×
“The muscle–brain axis has emerged as a significant area of research, highlighting how skeletal muscles influence brain function, particularly through the modulation of the KYN pathway [336–338].”
Agudelo, L. Z., Femenía, T., Orhan, F., Porsmyr-Palmertz, M., Goiny, M., Martinez-Redondo, V., Correia, J. C., Izadi, M., Bhat, M., Schuppe-Koistinen, I., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.051 · Cited by 739
Kynurenine pathway metabolism and the microbiota-gut-brain axis
Kennedy, P. J., Cryan, J. F., Dinan, T. G., & Clarke, G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.002 · Cited by 724 · cited 2×
“In recent years, the KYN pathway, the primary route for Trp metabolism, has been recognized as a crucial mediator of several body–brain axes, including the gut microbiome– brain axis, the muscle–brain axis, and other systemic connections [293–297].”
Quinolinic acid, the inescapable neurotoxin
Guillemin, G. J. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08485.x · Cited by 595 · cited 1×
“Researchers found that QUIN could increase oxidative stress by promoting the formation of free radicals, particularly in the context of inflammation [89–91].”
The Gut–Brain Axis and the Microbiome: Mechanisms and Clinical Implications
Osadchiy, V., Martin, C. R., & Mayer, E. A. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.10.002 · Cited by 555 · cited 2×
“The gut microbiome–brain axis, a bidirectional communication network between the gut microbiota and the CNS, has emerged as a key regulator of brain function and behavior [303–305].”
Singel, D. J., & Stamler, J. S. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.060603.090918 · Cited by 481 · cited 1×
“Third-order interactions involve complex neural networks where signals propagate through multiple neurons and feedback loops [421,422].”
What are higher-order networks?
Bick, C., Gross, E., Harrington, H. A., & Schaub, M. T. (2023) · SIAM Review · doi:10.1137/21m1414024 · Cited by 420
Quinolinic acid: an endogenous neurotoxin with multiple targets
Lugo-Huitrón, R., Ugalde Muñiz, P., Pineda, B., Pedraza-Chaverrí, J., Ríos, C., & Pérez-de la Cruz, V. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/104024 · Cited by 394
Lugo-Huitrón, R., Blanco-Ayala, T., Ugalde-Muñiz, P., Carrillo-Mora, P., Pedraza-Chaverrí, J., Silva-Adaya, D., Maldonado, P. D., Torres, I., Pinzón, E., Ortiz-Islas, E., et al. (2011) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2011.07.002 · Cited by 346 · cited 4×
“KYNA is particularly noted for its ability to neutralize ROS and reduce lipid peroxidation, which is critical in preventing oxidative damage to cell membranes [40,116–119].”
InfluentialThe kynurenine pathway and neurodegenerative disease
Maddison, D. C., & Giorgini, F. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.03.002 · Cited by 309
Behan, W. M. H., McDonald, M., Darlington, L. G., & Stone, T. W. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702940 · Cited by 225 · cited 2×
“It exerts its toxic effects primarily through the overactivation of N-methyl-D-aspartate (NMDA) receptors, leading to an excessive influx of calcium ions into neurons [88,89,142,143].”
A complex systems approach to aging biology
Cohen, A. A., Ferrucci, L., Fülöp, T., Gravel, D., Hao, N., Kriete, A., Levine, M. E., Lipsitz, L. A., Olde Rikkert, M. G. M., Rutenberg, A., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00252-6 · Cited by 221 · cited 2×
“Biological systems are regulated by feedback loops, which can be either negative or positive [379,472,473].”
Current perspectives on gut microbiome dysbiosis and depression
Capuco, A., Urits, I., Hasoon, J., Chun, R., Gerald, B., Wang, J. K., Kassem, H., Ngo, A. L., Abd-Elsayed, A., Simopoulos, T., et al. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01272-7 · Cited by 216 · cited 1×
“This modulation of Trp metabolism by gut bacteria highlights how changes in the microbiome can directly influence brain health, especially in conditions like depression, anxiety, and neurodegenerative diseases [315–317].”
Mithaiwala, M. N., Santana-Coelho, D., Porter, G. A., & O’Connor, J. C. (2021) · Cells · doi:10.3390/cells10061548 · Cited by 190
The cross talk between microbiota and the immune system: metabolites take center stage
Shapiro, H., Thaiss, C. A., Levy, M., & Elinav, E. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.07.003 · Cited by 189
IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
Huang, Y.-S., Ogbechi, J., Clanchy, F. I., Williams, R. O., & Stone, T. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00388 · Cited by 187 · cited 1×
“The main challenge lies in reconciling discrepancies between in vitro and in vivo studies, particularly due to the complex interplay of metabolic and neural processes that are difficult to replicate outside a living organism [47,200,525].”
Indole‐3‐propionic acid attenuates neuronal damage and oxidative stress in the ischemic hippocampus
Hwang, I. K., Yoo, K., Li, H., Park, O. K., Lee, C. H., Choi, J. H., Jeong, Y., Lee, Y. L., Kim, Y., Kwon, Y., et al. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22030 · Cited by 186
Role of Kynurenines in the Central and Peripherial Nervous Systems
Nemeth, H., Toldi, J., & Vecsei, L. (2005) · Current Neurovascular Research · doi:10.2174/1567202054368326 · Cited by 169 · cited 1×
“The KYN pathway is crucial in Trp metabolism, generating metabolites that play key roles in both the central nervous and immune systems [121–124].”
Self-citationSarcopenia and Cognitive Decline in Older Adults: Targeting the Muscle–Brain Axis
Arosio, B., Calvani, R., Ferri, E., Coelho-Junior, H. J., Carandina, A., Campanelli, F., Ghiglieri, V., Marzetti, E., & Picca, A. (2023) · Nutrients · doi:10.3390/nu15081853 · Cited by 165 · cited 1×
“The muscle–brain axis has emerged as a significant area of research, highlighting how skeletal muscles influence brain function, particularly through the modulation of the KYN pathway [336–338].”
Mathematical models in microbial systems biology
Stelling, J. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.08.004 · Cited by 164 · cited 1×
“Mathematical modeling is central to systems biology [461–463].”
Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR)
Seok, S.-H., Ma, Z.-X., Feltenberger, J. B., Chen, H., Chen, H., Scarlett, C., Lin, Z., Satyshur, K. A., Cortopassi, M., Jefcoate, C. R., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000631 · Cited by 157 · cited 1×
“Over the decades, it has become clear that certain KYN metabolites, such as KYN, KYNA, AA, XA, and CA function as ligands for the AhR, a key transcription factor involved in immune regulation [286–288].”
Nobel Turing Challenge: creating the engine for scientific discovery
Kitano, H. (2021) · npj Systems Biology and Applications · doi:10.1038/s41540-021-00189-3 · Cited by 149
Valotto Neto, L. J., Reverete de Araujo, M., Moretti Junior, R. C., Mendes Machado, N., Joshi, R. K., dos Santos Buglio, D., Barbalho Lamas, C., Direito, R., Fornari Laurindo, L., Tanaka, M., et al. (2024) · Antioxidants · doi:10.3390/antiox13040393 · Cited by 146
Self-citationKynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword?
Ostapiuk, A., & Urbanska, E. M. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13768 · Cited by 142 · cited 2×
“KYNA has been identified for its neuroprotective effects through antioxidant mechanisms, and historical research has gradually uncovered its contributions to protecting the brain from oxidative damage [41,108,109].”
Huang, Y., Zhao, M., Chen, X., Zhang, R., Le, A., Hong, M., Zhang, Y., Jia, L., Zang, W., Jiang, C., et al. (2023) · Aging and disease · doi:10.14336/ad.2022.0916 · Cited by 138 · cited 4×
“Historical research has uncovered their ability to generate reactive oxygen species (ROS), implicating them in the progression of neurodegenerative diseases through oxidative damage rather than excitotoxicity [80–82] (Table 1).”
InfluentialFuertig, R., Azzinnari, D., Bergamini, G., Cathomas, F., Sigrist, H., Seifritz, E., Vavassori, S., Luippold, A., Hengerer, B., Ceci, A., et al. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.12.020 · Cited by 135 · cited 1×
“In recent years, the KYN pathway, the primary route for Trp metabolism, has been recognized as a crucial mediator of several body–brain axes, including the gut microbiome– brain axis, the muscle–brain axis, and other systemic connections [293–297].”
Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders
Li, D., Yu, S., Long, Y., Shi, A., Deng, J., Ma, Y., Wen, J., Li, X., Liu, S., Zhang, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.985378 · Cited by 129 · cited 1×
“It exerts its toxic effects primarily through the overactivation of N-methyl-D-aspartate (NMDA) receptors, leading to an excessive influx of calcium ions into neurons [88,89,142,143].”
Parrott, J. M., Redus, L., & O’Connor, J. C. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0590-y · Cited by 112 · cited 1×
“Furthermore, the lipopolysaccharide (LPS)-induced activation of the KYN pathway was investigated, specifically how immune system activation affects KYN metabolism in the brain [295].”
The Role of the Microbiome-Brain-Gut Axis in the Pathogenesis of Depressive Disorder
Młynarska, E., Gadzinowska, J., Tokarek, J., Forycka, J., Szuman, A., Franczyk, B., & Rysz, J. (2022) · Nutrients · doi:10.3390/nu14091921 · Cited by 109 · cited 2×
“…have uncovered the critical role of the KYN pathway in Gut microbiota can influence Trp metabolism, diverting it through the KYN pathway and producing metabolites that affect brain processes. mediating this axis, particularly in the context of mental health and neuroinflammation [306–308].”
Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis
Guillemin, G. J., Meininger, V., & Brew, B. J. (2005) · Neurodegenerative Diseases · doi:10.1159/000089622 · Cited by 105 · cited 1×
“The excitotoxic properties of KYN pathway metabolites, especially QUIN, have been widely investigated for their critical involvement in neurodegenerative diseases [136–138].”
Strasser, B., Becker, K., Fuchs, D., & Gostner, J. M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.030 · Cited by 97
Biological feedback control-Respect the loops
El-Samad, H. (2021) · Cell Systems · doi:10.1016/j.cels.2021.05.004 · Cited by 90
Visceral Inflammation and Immune Activation Stress the Brain
Holzer, P., Farzi, A., Hassan, A. M., Zenz, G., Jačan, A., & Reichmann, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01613 · Cited by 84
Kynurenic acid antagonists and kynurenine pathway inhibitors
Stone, T. W. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.4.633 · Cited by 79
Hormones, Metabolism and the Benefits of Exercise
(2017) · Research and Perspectives in Endocrine Interactions · doi:10.1007/978-3-319-72790-5 · Cited by 44
Simoni, G., Reali, F., Priami, C., & Marchetti, L. (2019) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1459 · Cited by 26
Cited by
Parkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation
Tanaka, M. (2025) · doi:10.20944/preprints202506.2099.v2 · Cited by 57
Self-citationQuinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design
Tanaka, M., Szatmári, I., & Vécsei, L. (2025) · doi:10.20944/preprints202503.2399.v1 · Cited by 30
Self-citationTanaka, M. (2024) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/197425 · Cited by 27
Self-citationTanaka, M., Battaglia, S., & Liloia, D. (2025) · Biomedicines · doi:10.3390/biomedicines13051045 · Cited by 24
“From a theoretical standpoint, these studies expand upon established frameworks in neurodegeneration research by combining molecular biology, biomedical engineering, and clinical insights [98,99].”
Self-citationFrom Microbial Switches to Metabolic Sensors: Rewiring the Gut–Brain Kynurenine Circuit
Tanaka, M., & Vécsei, L. (2025) · doi:10.20944/preprints202506.0880.v1 · Cited by 24
Self-citation
Metadata
- Authors
- Tanaka, M., Szabó, Á., & Vécsei, L.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2024-11-27
- Volume
- 25
- Issue
- 23
- Pages
- 12767
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4404755699
- Cited by
- 58
- References
- 41
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.